Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 14 of 20
Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957
Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients
NCT02152345
Tailored Approaches to Stroke Health Education
NCT01909271
Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study
NCT02092987
Addressing Hospital Patient Information Needs Using Information Technology
NCT01970852
Duration of Red Blood Cell Storage Prior to Transfusion
NCT02087514
Bone Remodeling After Immediate Implant Placement With and Without Bone Grafting
NCT02174198
A Pilot Study Using Text Messaging to Communicate With Adolescent Females in the Pediatric Emergency Department
NCT02093884
Alpers Huttenlocher Natural History Study
NCT03034512
Efficacy Study of Interactive Web Application for Problem Solving in Diabetes Management
NCT02021591
PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
NCT02087553
Nitrous Oxide Analgesia Vaso-occlusive Crisis
NCT01891812
Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes
NCT01993017
PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
NCT01974050
Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma
NCT02775786
Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
NCT01998035
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
NCT02790242
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
NCT01980823
Study of the Effects of Negative Emotions on Endothelial Function
NCT01909895
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
NCT02018042
Adult Influenza Vaccination Text Message Reminders
NCT01942824
Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT
NCT02029742
Pharmacokinetic Alterations During ECMO
NCT01938079
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
NCT01950780
Intervening to Improve Infant Health in Ghana
NCT01335490
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT01855607
Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
NCT02236754
Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders
NCT01690494
Volumes of Administration for Intranasal Midazolam
NCT01948908
Two Dose Epidural Morphine for Post-cesarean Analgesia
NCT01844206
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study
NCT01285362
A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls
NCT01813123
Prenatal Microarray Follow-Up Study
NCT02160938
Nitrous Oxide Vasodilation Healthy Adult Volunteers
NCT01785030
Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis
NCT01222260
Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
NCT01764269
Development of Melt Organic Baking Fat for Reducing Child Obesity
NCT02346994
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
NCT01614106
Pilot Text Message for Influenza Vaccination
NCT01761734
The Effect of Body Mass Index on Etonogestrel Hormone Levels in Women Using the Single-rod Contraceptive Implant
NCT01855620
Effect of G6PD Deficiency on Red Blood Cell Storage
NCT04081272
Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men
NCT01559805
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
NCT01847001
LIFT: Lifestyle Interventions For Two
NCT01616147
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
NCT01530880
Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma
NCT01731886
Primary-care-provider Identification And Notification
NCT01984645
Preventing Drug Abuse Among Hispanic Adolescents
NCT02375516
Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children
NCT01662583
Quick Start Insertion of Mirena and ParaGard
NCT01730911
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Columbia University pipeline card: 958 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.